Differences in larval survival and IgG response patterns in long-lasting infections by Trichinella spiralis, Trichinella britovi and Trichinella pseudospiralis in pigs.


Journal

Parasites & vectors
ISSN: 1756-3305
Titre abrégé: Parasit Vectors
Pays: England
ID NLM: 101462774

Informations de publication

Date de publication:
16 Oct 2020
Historique:
received: 24 07 2020
accepted: 07 10 2020
entrez: 17 10 2020
pubmed: 18 10 2020
medline: 1 6 2021
Statut: epublish

Résumé

Domesticated and wild swine play an important role as reservoir hosts of Trichinella spp. and a source of infection for humans. Little is known about the survival of Trichinella larvae in muscles and the duration of anti-Trichinella antibodies in pigs with long-lasting infections. Sixty pigs were divided into three groups of 20 animals and infected with 10,000 larvae of Trichinella spiralis, Trichinella britovi or Trichinella pseudospiralis. Four pigs from each group were sacrificed at 2, 6, 12, 18 and 24 months post-infection (p.i.) and the number of larvae per gram (LPG) of muscles was calculated. Serum samples were tested by ELISA and western blot using excretory/secretory (ES) and crude antigens. Trichinella spiralis showed the highest infectivity and immunogenicity in pigs and larvae survived in pig muscles for up to 2 years p.i. In these pigs, the IgG level significantly increased at 30 days p.i. and reached a peak at about 60 days p.i., remaining stable until the end of the experiment. In T. britovi-infected pigs, LPG was about 70 times lower than for T. spiralis at 2 months p.i. and only very few infecting larvae were detected at 6 months p.i., whereas no larvae were detected at 12, 18 and 24 months p.i. At 6 months p.i., degenerated/calcified larvae and cysts were detected in the muscles by trichinoscopy and histology. The IgG pattern showed by T. britovi-infected pigs was similar to that of T. spiralis-infected pigs, although seroconversion occurred some days later. The larval burden of T. pseudospiralis was slightly greater than for T. britovi at 2 months p.i., but no larvae were detected at 6 and 12 months p.i. In T. pseudospiralis-infected pigs, seroconversion occurred slowly, as in T. britovi-infected pigs. The IgG level showed a significant drop at 6 months p.i. and declining to the cut-off value at 12 months p.i. The longer survival of T. spiralis in pigs in comparison with the other two species highlights its exceptional dissemination potential. These results provide an explanation of the controversial data collected by parasitological and serological tools in the course of epidemiological investigations.

Sections du résumé

BACKGROUND BACKGROUND
Domesticated and wild swine play an important role as reservoir hosts of Trichinella spp. and a source of infection for humans. Little is known about the survival of Trichinella larvae in muscles and the duration of anti-Trichinella antibodies in pigs with long-lasting infections.
METHODS METHODS
Sixty pigs were divided into three groups of 20 animals and infected with 10,000 larvae of Trichinella spiralis, Trichinella britovi or Trichinella pseudospiralis. Four pigs from each group were sacrificed at 2, 6, 12, 18 and 24 months post-infection (p.i.) and the number of larvae per gram (LPG) of muscles was calculated. Serum samples were tested by ELISA and western blot using excretory/secretory (ES) and crude antigens.
RESULTS RESULTS
Trichinella spiralis showed the highest infectivity and immunogenicity in pigs and larvae survived in pig muscles for up to 2 years p.i. In these pigs, the IgG level significantly increased at 30 days p.i. and reached a peak at about 60 days p.i., remaining stable until the end of the experiment. In T. britovi-infected pigs, LPG was about 70 times lower than for T. spiralis at 2 months p.i. and only very few infecting larvae were detected at 6 months p.i., whereas no larvae were detected at 12, 18 and 24 months p.i. At 6 months p.i., degenerated/calcified larvae and cysts were detected in the muscles by trichinoscopy and histology. The IgG pattern showed by T. britovi-infected pigs was similar to that of T. spiralis-infected pigs, although seroconversion occurred some days later. The larval burden of T. pseudospiralis was slightly greater than for T. britovi at 2 months p.i., but no larvae were detected at 6 and 12 months p.i. In T. pseudospiralis-infected pigs, seroconversion occurred slowly, as in T. britovi-infected pigs. The IgG level showed a significant drop at 6 months p.i. and declining to the cut-off value at 12 months p.i.
CONCLUSIONS CONCLUSIONS
The longer survival of T. spiralis in pigs in comparison with the other two species highlights its exceptional dissemination potential. These results provide an explanation of the controversial data collected by parasitological and serological tools in the course of epidemiological investigations.

Identifiants

pubmed: 33066824
doi: 10.1186/s13071-020-04394-7
pii: 10.1186/s13071-020-04394-7
pmc: PMC7566126
doi:

Substances chimiques

Immunoglobulin G 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

520

Subventions

Organisme : European Commission
ID : European Commission, contract SANCO/2006/FOOD SAFETY/032

Références

Berl Munch Tierarztl Wochenschr. 1995 May;108(5):167-74
pubmed: 7575386
Acta Vet Hung. 2019 Mar;67(1):40-50
pubmed: 30922089
Vet Parasitol. 2012 Jun 8;187(1-2):323-7
pubmed: 22244535
Int J Parasitol. 2013 Nov;43(12-13):983-97
pubmed: 23816802
Vet Parasitol. 2010 Aug 27;172(1-2):150-4
pubmed: 20471753
J Parasitol. 2001 Apr;87(2):309-14
pubmed: 11318560
Int J Parasitol. 2000 Feb;30(2):215-21
pubmed: 10704604
Vet Parasitol. 2014 Jan 31;199(3-4):179-90
pubmed: 24225004
EFSA J. 2019 Dec 11;17(12):e05926
pubmed: 32626211
Korean J Parasitol. 2015 Apr;53(2):233-6
pubmed: 25925185
Vet Parasitol. 2014 Aug 29;204(3-4):426-9
pubmed: 24867274
Vet Parasitol. 2018 Oct 15;262:1-5
pubmed: 30389004
Vet Parasitol. 2014 Oct 15;205(3-4):653-65
pubmed: 25182211
Vet Parasitol. 2009 Feb 23;159(3-4):358-60
pubmed: 19081197
Int Arch Allergy Immunol. 1999 Aug;119(4):291-6
pubmed: 10474034
Vet Parasitol. 2009 Feb 23;159(3-4):281-4
pubmed: 19054618
Vet Parasitol. 2015 Sep 15;212(3-4):257-61
pubmed: 26238657
Vet Parasitol. 2013 May 20;194(2-4):133-5
pubmed: 23422779
Int J Parasitol. 1999 Jul;29(7):1129-31
pubmed: 10501623
Vet Parasitol. 1998 Jan 31;74(2-4):215-28
pubmed: 9580432
Parasite. 2001 Jun;8(2 Suppl):S106-8
pubmed: 11484328
Int J Parasitol. 2020 Apr;50(4):277-287
pubmed: 32171846
EFSA J. 2017 Dec 12;15(12):e05077
pubmed: 32625371
Vet Parasitol. 2020 Mar;279:109052
pubmed: 32050131
Acta Parasitol. 2016 Mar;61(2):205-11
pubmed: 27078642
Proc Natl Acad Sci U S A. 2006 May 9;103(19):7354-9
pubmed: 16651518
Vector Borne Zoonotic Dis. 2016 Sep;16(9):604-10
pubmed: 27315523
Vet Parasitol. 2013 May 20;194(2-4):136-8
pubmed: 23453823
Exp Parasitol. 2020 May;212:107874
pubmed: 32179068
Vet Parasitol. 2009 Feb 23;159(3-4):218-21
pubmed: 19059726
Vet Parasitol. 2005 Sep 5;132(1-2):85-90
pubmed: 15985334
Vet Parasitol. 2005 Sep 5;132(1-2):155-7
pubmed: 15978729
Immunology. 1994 Mar;81(3):475-9
pubmed: 8206519
Emerg Infect Dis. 2011 Dec;17(12):2194-202
pubmed: 22172230
Vet Parasitol. 2005 Sep 5;132(1-2):119-23
pubmed: 15990231
Parasit Vectors. 2018 Dec 12;11(1):631
pubmed: 30541617
Euro Surveill. 2002 Oct;7(10):136-8
pubmed: 12631992
Parasit Vectors. 2014 Apr 07;7:171
pubmed: 24708795
Vet Q. 1991 Oct;13(4):190-8
pubmed: 1776233
Int J Parasitol. 1999 Nov;29(11):1825-39
pubmed: 10616929
EFSA J. 2018 Dec 12;16(12):e05500
pubmed: 32625785
Trends Parasitol. 2014 Jan;30(1):4-11
pubmed: 24314577
Int J Parasitol. 2012 Oct;42(11):1017-23
pubmed: 22995743
Vet Parasitol. 2007 Sep 30;148(3-4):371-4
pubmed: 17646053
Vet Parasitol. 2009 Feb 23;159(3-4):361-3
pubmed: 19041178
Nat Commun. 2016 Feb 01;7:10513
pubmed: 26830005
Am J Trop Med Hyg. 2003 Apr;68(4):463-4
pubmed: 12875297
Eur J Clin Microbiol Infect Dis. 2007 Sep;26(9):641-5
pubmed: 17610096
Vet Parasitol. 2009 Dec 23;166(3-4):241-8
pubmed: 19819075

Auteurs

Edoardo Pozio (E)

Department of Infectious Diseases, Istituto Superiore di Sanità, viale Regina Elena 299, 00161, Rome, Italy.

Giuseppe Merialdi (G)

Istituto Zooprofilattico Sperimentale of Lombardy and Emilia Romagna, via Pietro Fiorini 5, 40127, Bologna, Italy.

Elio Licata (E)

Department of Public Health, Azienda Unità Sanitaria Locale of Modena, Strada Martiniana 21, 4112, Baggiovara, Modena, Italy.

Giacinto Della Casa (G)

Consiglio per la ricerca in agricoltura e l'analisi dell'economia agraria, Centro di Ricerca Zootecnica e Acquacoltura, Sede di Modena, via Beccastecca 345, 41018, S. Cesario sul Panaro (MO), Italy.

Massimo Fabiani (M)

Department of Infectious Diseases, Istituto Superiore di Sanità, viale Regina Elena 299, 00161, Rome, Italy.

Marco Amati (M)

Department of Infectious Diseases, Istituto Superiore di Sanità, viale Regina Elena 299, 00161, Rome, Italy.

Simona Cherchi (S)

Department of Infectious Diseases, Istituto Superiore di Sanità, viale Regina Elena 299, 00161, Rome, Italy.

Mattia Ramini (M)

Istituto Zooprofilattico Sperimentale of Lombardy and Emilia Romagna, via Pietro Fiorini 5, 40127, Bologna, Italy.

Valerio Faeti (V)

Consiglio per la ricerca in agricoltura e l'analisi dell'economia agraria, Centro di Ricerca Zootecnica e Acquacoltura, Sede di Modena, via Beccastecca 345, 41018, S. Cesario sul Panaro (MO), Italy.

Maria Interisano (M)

Department of Infectious Diseases, Istituto Superiore di Sanità, viale Regina Elena 299, 00161, Rome, Italy.

Alessandra Ludovisi (A)

Department of Infectious Diseases, Istituto Superiore di Sanità, viale Regina Elena 299, 00161, Rome, Italy.

Gianluca Rugna (G)

Istituto Zooprofilattico Sperimentale of Lombardy and Emilia Romagna, via Pietro Fiorini 5, 40127, Bologna, Italy.

Gianluca Marucci (G)

Department of Infectious Diseases, Istituto Superiore di Sanità, viale Regina Elena 299, 00161, Rome, Italy.

Daniele Tonanzi (D)

Department of Infectious Diseases, Istituto Superiore di Sanità, viale Regina Elena 299, 00161, Rome, Italy.

Maria Angeles Gómez-Morales (MA)

Department of Infectious Diseases, Istituto Superiore di Sanità, viale Regina Elena 299, 00161, Rome, Italy. mariaangeles.gomezmorales@iss.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH